Robert S. Parker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Robert S. Parker has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Gilles Clermont
University of Pittsburgh
2 shared publications Alisa Urbano
Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
1 shared publication- Carol A. Bertrand
Department of Cell Biology and Physiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA
1 shared publication - David Swigon
Department of Mathematics, University of Pittsburgh
1 shared publication - David Z. D'Argenio
Department of Biomedical Engineering, University of Southern California, Los Angeles, USA
1 shared publication - Ericka Mochan
Department of Chemical and Petroleum Engineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15213, USA; Department of Mathematics and Data Analytics, Carlow University, Pittsburgh, PA 15213, USA
1 shared publication
Latest Publications
- 15 February 2023
- Published by Elsevier in Journal of Critical Care
- Vol. 74, 154204
Modeling sepsis-induced organ failure
- 15 February 2023
- Published by Elsevier in Journal of Critical Care
- Vol. 74, 154204
Modeling sepsis-induced organ failure
- Open Access
- 1 January 2018
- Published by Elsevier in IFAC-PapersOnLine
- Vol. 51 (19) , 102-103
Physiologically-Based Model of Fluid Absorption and Mucociliary Clearance in Cystic Fibrosis
- 1 January 2018
- Published by Elsevier in IFAC-PapersOnLine
- Vol. 51 (19) , 102-103
Open AccessPhysiologically-Based Model of Fluid Absorption and Mucociliary Clearance in Cystic Fibrosis
- Open Access
- 1 December 2017
- Published by American Society for Microbiology in Journal of Virology
- Vol. 91 (23) , e00395-17
Discrete Dynamical Modeling of Influenza Virus Infection Suggests Age-Dependent Differences in Immunity
Immunosenescence, an age-related decline in immune function, is a major contributor to morbidity and mortality in the elderly. Older hosts exhibit a delayed onset of immunity and prolonged inflammation after an infection, leading to excess damage and a greater likelihood of death. Our study applies a rule-based model to infer which components of the immune response are most changed in an aged host. Two groups of BALB/c mice (aged 12 to 16 weeks and 72 to 76 weeks) were infected with 2 inocula: a survivable dose of 50 PFU and a lethal dose of 500 PFU. Data were measured at 10 points over 19 days in the sublethal case and at 6 points over 7 days in the lethal case, after which all mice had died. Data varied primarily in the onset of immunity, particularly the inflammatory response, which led to a 2-day delay in the clearance of the virus from older hosts in the sublethal cohort. We developed a Boolean model to describe the interactions between the virus and 21 immune components, including cells, chemokines, and cytokines, of innate and adaptive immunity. The model identifies distinct sets of rules for each age group by using Boolean operators to describe the complex series of interactions that activate and deactivate immune components. Our model accurately simulates the immune responses of mice of both ages and with both inocula included in the data (95% accurate for younger mice and 94% accurate for older mice) and shows distinct rule choices for the innate immunity arm of the model between younger and aging mice in response to influenza A virus infection.IMPORTANCEInfluenza virus infection causes high morbidity and mortality rates every year, especially in the elderly. The elderly tend to have a delayed onset of many immune responses as well as prolonged inflammatory responses, leading to an overall weakened response to infection. Many of the details of immune mechanisms that change with age are currently not well understood. We present a rule-based model of the intrahost immune response to influenza virus infection. The model is fit to experimental data for young and old mice infected with influenza virus. We generated distinct sets of rules for each age group to capture the temporal differences seen in the immune responses of these mice. These rules describe a network of interactions leading to either clearance of the virus or death of the host, depending on the initial dosage of the virus. Our models clearly demonstrate differences in these two age groups, particularly in the innate immune responses.
- 1 December 2017
- Published by American Society for Microbiology in Journal of Virology
- Vol. 91 (23) , e00395-17
Open AccessDiscrete Dynamical Modeling of Influenza Virus Infection Suggests Age-Dependent Differences in Immunity
Immunosenescence, an age-related decline in immune function, is a major contributor to morbidity and mortality in the elderly. Older hosts exhibit a delayed onset of immunity and prolonged inflammation after an infection, leading to excess damage and a greater likelihood of death. Our study applies a rule-based model to infer which components of the immune response are most changed in an aged host. Two groups of BALB/c mice (aged 12 to 16 weeks and 72 to 76 weeks) were infected with 2 inocula: a survivable dose of 50 PFU and a lethal dose of 500 PFU. Data were measured at 10 points over 19 days in the sublethal case and at 6 points over 7 days in the lethal case, after which all mice had died. Data varied primarily in the onset of immunity, particularly the inflammatory response, which led to a 2-day delay in the clearance of the virus from older hosts in the sublethal cohort. We developed a Boolean model to describe the interactions between the virus and 21 immune components, including cells, chemokines, and cytokines, of innate and adaptive immunity. The model identifies distinct sets of rules for each age group by using Boolean operators to describe the complex series of interactions that activate and deactivate immune components. Our model accurately simulates the immune responses of mice of both ages and with both inocula included in the data (95% accurate for younger mice and 94% accurate for older mice) and shows distinct rule choices for the innate immunity arm of the model between younger and aging mice in response to influenza A virus infection.IMPORTANCEInfluenza virus infection causes high morbidity and mortality rates every year, especially in the elderly. The elderly tend to have a delayed onset of many immune responses as well as prolonged inflammatory responses, leading to an overall weakened response to infection. Many of the details of immune mechanisms that change with age are currently not well understood. We present a rule-based model of the intrahost immune response to influenza virus infection. The model is fit to experimental data for young and old mice infected with influenza virus. We generated distinct sets of rules for each age group to capture the temporal differences seen in the immune responses of these mice. These rules describe a network of interactions leading to either clearance of the virus or death of the host, depending on the initial dosage of the virus. Our models clearly demonstrate differences in these two age groups, particularly in the innate immune responses.
- Open Access
- 30 January 2017
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Life Sciences Letters
- Vol. 2 (3) , 17-18
Guest Editorial: Special Issue on the Foundations of Systems Biology in Engineering (FOSBE)
The complete sequencing of the human genome has undoubtedly advanced the study of biology and the practice of medicine, including some dramatic and rapid advances in human health. This progress has been slowed, however, by the challenge of understanding how the genetic players, and their regulation, interact to yield systemic responses to disease and treatment. Taking a puzzle as an analogy for life, the landmark achievement of identifying the human genome provided a list of the possible puzzle pieces, but it did not provide the completed picture on the cover. The search since has focused on the relationships between this genomic information and the (individual or patient) systemic response or function—the “omics” efforts in mapping proteins (proteomics) and metabolites (metabolomics). The primary avenues in this search are: 1) defining the causal connections between the plethora of transcriptional, protein, and metabolite players; 2) linking these microscale networks to system-level response; and 3) capturing the dynamics of the system in response to changes at lower scales. The fields of systems biology, and its translational science counterpart systems medicine, have emerged as the bridge between reductionist molecular and cellular biology approaches and the systems-level understanding required to use this knowledge to advance the human condition.
- 30 January 2017
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Life Sciences Letters
- Vol. 2 (3) , 17-18
Open AccessGuest Editorial: Special Issue on the Foundations of Systems Biology in Engineering (FOSBE)
The complete sequencing of the human genome has undoubtedly advanced the study of biology and the practice of medicine, including some dramatic and rapid advances in human health. This progress has been slowed, however, by the challenge of understanding how the genetic players, and their regulation, interact to yield systemic responses to disease and treatment. Taking a puzzle as an analogy for life, the landmark achievement of identifying the human genome provided a list of the possible puzzle pieces, but it did not provide the completed picture on the cover. The search since has focused on the relationships between this genomic information and the (individual or patient) systemic response or function—the “omics” efforts in mapping proteins (proteomics) and metabolites (metabolomics). The primary avenues in this search are: 1) defining the causal connections between the plethora of transcriptional, protein, and metabolite players; 2) linking these microscale networks to system-level response; and 3) capturing the dynamics of the system in response to changes at lower scales. The fields of systems biology, and its translational science counterpart systems medicine, have emerged as the bridge between reductionist molecular and cellular biology approaches and the systems-level understanding required to use this knowledge to advance the human condition.
- Open Access
- 15 June 2009
- Published by Science Insights in Pakistan Journal of Nutrition
- Vol. 8 (7) , 1000-1004
Vitamin A Content of Southeastern Nigerian Vegetable Dishes, Their Consumption Pattern and Contribution to Vitamin A Requirement of Pregnant Women in Calabar Urban, Nigeria
The frequency of consumption of six dark green leafy vegetables (DGLV), their vitamin A values, and the relative contribution of these vegetables to vitamin A requirement of pregnant women in Calabar urban was assessed. A total of 101 pregnant women attending clinic at the University of Calabar Teaching Hospital (UCTH), Calabar were covered. Using a food-frequency questionnaire, the consumption pattern of the DGLV was assessed. The study revealed that 100% of the women used the six leafy vegetables chiefly in form of soups and pottages. Ikong ubong (Telfairia occidentalis), Mon-mon ikong (Talinum triangulare) and Afang (Gnetum africanum) were extensively consumed by the women with slight variation in their patterns of consumption, while Inyang afia (Amaranthus hybridus), Atama (Heinsia crinita) and Editan (Lasianthera africana) were less frequently consumed. High Performance Liquid Chromatography (HPLC) analysis showed the following values of vitamin A in μg RE/100g for the vegetables: Ikong ubong 860±0.10, Mon-mon ikong 39±0.04, Inyang afia 853±0.19, Afang 44±0.18, Atama 26±0.04 and Editan 36±0.04. Also, Ikong soup with a vitamin A value of 4759.75±672 μg RE/100g per portion size (200g) made the highest contribution (255 %) to the vitamin A requirement of the pregnant women, while Atama as Abak (Elaeis guinensis pulp puree) soup (portion size: 150g) with a vitamin A value of 214.33±46 μg RE/100g made the least contribution (12%) to vitamin A requirement in the women. The usual dietary habit of pregnant women in Calabar can sustain their vitamin A status because with the only exception of Atama (Abak soup), a portion size of each of the other green vegetables contain higher levels of vitamin A than the required daily intake of the women.
- 15 June 2009
- Published by Science Insights in Pakistan Journal of Nutrition
- Vol. 8 (7) , 1000-1004
Open AccessVitamin A Content of Southeastern Nigerian Vegetable Dishes, Their Consumption Pattern and Contribution to Vitamin A Requirement of Pregnant Women in Calabar Urban, Nigeria
The frequency of consumption of six dark green leafy vegetables (DGLV), their vitamin A values, and the relative contribution of these vegetables to vitamin A requirement of pregnant women in Calabar urban was assessed. A total of 101 pregnant women attending clinic at the University of Calabar Teaching Hospital (UCTH), Calabar were covered. Using a food-frequency questionnaire, the consumption pattern of the DGLV was assessed. The study revealed that 100% of the women used the six leafy vegetables chiefly in form of soups and pottages. Ikong ubong (Telfairia occidentalis), Mon-mon ikong (Talinum triangulare) and Afang (Gnetum africanum) were extensively consumed by the women with slight variation in their patterns of consumption, while Inyang afia (Amaranthus hybridus), Atama (Heinsia crinita) and Editan (Lasianthera africana) were less frequently consumed. High Performance Liquid Chromatography (HPLC) analysis showed the following values of vitamin A in μg RE/100g for the vegetables: Ikong ubong 860±0.10, Mon-mon ikong 39±0.04, Inyang afia 853±0.19, Afang 44±0.18, Atama 26±0.04 and Editan 36±0.04. Also, Ikong soup with a vitamin A value of 4759.75±672 μg RE/100g per portion size (200g) made the highest contribution (255 %) to the vitamin A requirement of the pregnant women, while Atama as Abak (Elaeis guinensis pulp puree) soup (portion size: 150g) with a vitamin A value of 214.33±46 μg RE/100g made the least contribution (12%) to vitamin A requirement in the women. The usual dietary habit of pregnant women in Calabar can sustain their vitamin A status because with the only exception of Atama (Abak soup), a portion size of each of the other green vegetables contain higher levels of vitamin A than the required daily intake of the women.
- Open Access
- 1 October 2006
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 12 (19) , 5826-5833
A Mass Balance and Disposition Study of the DNA Methyltransferase Inhibitor Zebularine (NSC 309132) and Three of Its Metabolites in Mice
Purpose: To elucidate the in vivo metabolic fate of zebularine (NSC 309132), a DNA methyltransferase inhibitor proposed for clinical evaluation in the treatment of cancer. Experimental Design: Male, CD2F1 mice were dosed i.v. with 100 mg/kg 2-[14C]zebularine. At specified times between 5 and 1,440 minutes, mice were euthanized. Plasma, organs, carcass, urine, and feces were collected and assayed for total radioactivity. Plasma and urine were also analyzed for zebularine and its metabolites with a previously validated high-pressure liquid chromatography assay. A similar experiment was done with 2-[14C]uridine, the proposed primary metabolite of zebularine. Results: Maximum plasma concentrations were 462, 306, 33.6, 21.7, and 11.5 μmol/L for total radioactivity, zebularine, uridine, uracil (each at 5 minutes), and dihydrouracil (at 15 minutes), respectively. Total radioactivity, zebularine, uridine, uracil, and dihydrouracil were rapidly eliminated from plasma, and after 45 minutes, none of the individual compounds could be quantitated by high-pressure liquid chromatography. Plasma data were consistent with sequential conversion of zebularine to uridine, uracil, and dihydrouracil. 2-Pyrimidinone was not observed. Prolonged retention of radioactivity, at concentrations higher than in plasma, was observed in tissues. Recovery of given radioactivity in urine (30.3% of dose), feces (0.4% of dose), cage wash (7.9% of dose), and tissues and carcass (6.1% of dose) after 24 hours implied that up to 55% of radioactivity was expired as 14CO2. Comparison of zebularine and uridine pharmacokinetic data indicated that ∼40% of the zebularine dose was converted to uridine. Conclusions: Zebularine is extensively and rapidly metabolized into endogenous compounds that are unlikely to have effects at the concentrations observed.
- 1 October 2006
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 12 (19) , 5826-5833
Open AccessA Mass Balance and Disposition Study of the DNA Methyltransferase Inhibitor Zebularine (NSC 309132) and Three of Its Metabolites in Mice
Purpose: To elucidate the in vivo metabolic fate of zebularine (NSC 309132), a DNA methyltransferase inhibitor proposed for clinical evaluation in the treatment of cancer. Experimental Design: Male, CD2F1 mice were dosed i.v. with 100 mg/kg 2-[14C]zebularine. At specified times between 5 and 1,440 minutes, mice were euthanized. Plasma, organs, carcass, urine, and feces were collected and assayed for total radioactivity. Plasma and urine were also analyzed for zebularine and its metabolites with a previously validated high-pressure liquid chromatography assay. A similar experiment was done with 2-[14C]uridine, the proposed primary metabolite of zebularine. Results: Maximum plasma concentrations were 462, 306, 33.6, 21.7, and 11.5 μmol/L for total radioactivity, zebularine, uridine, uracil (each at 5 minutes), and dihydrouracil (at 15 minutes), respectively. Total radioactivity, zebularine, uridine, uracil, and dihydrouracil were rapidly eliminated from plasma, and after 45 minutes, none of the individual compounds could be quantitated by high-pressure liquid chromatography. Plasma data were consistent with sequential conversion of zebularine to uridine, uracil, and dihydrouracil. 2-Pyrimidinone was not observed. Prolonged retention of radioactivity, at concentrations higher than in plasma, was observed in tissues. Recovery of given radioactivity in urine (30.3% of dose), feces (0.4% of dose), cage wash (7.9% of dose), and tissues and carcass (6.1% of dose) after 24 hours implied that up to 55% of radioactivity was expired as 14CO2. Comparison of zebularine and uridine pharmacokinetic data indicated that ∼40% of the zebularine dose was converted to uridine. Conclusions: Zebularine is extensively and rapidly metabolized into endogenous compounds that are unlikely to have effects at the concentrations observed.